'U snooze u lose': Judg­ment day for $100M biotech in­sid­er trad­ing scheme looms as son of for­mer Ari­ad di­rec­tor stands tri­al

A crim­i­nal tri­al that be­gins to­day in Man­hat­tan promis­es to un­rav­el a glob­al in­sid­er trad­ing ring that prof­it­ed off of non-pub­lic in­for­ma­tion about mul­ti­ple biotechs …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER